Abstract:The evaluation of the efficacy of a drug is a fundamental step in the development of new treatments or in personalized therapeutic strategies and patient management. Ideally, this evaluation should be rapid, possibly in real time, easy to perform and reliable. In addition, it should be associated with as few adverse effects as possible for the patient. In this study, we present a device designed to meet these goals for assessing therapeutic response. This theranostic device is based on the use of magnetic resonance imaging and spectroscopy for the diagnostic aspect and on the application of the convection-enhanced delivery technique for the therapeutic aspect. The miniaturized device is implantable and can be used in vivo in a target tissue. In this study, the device was applied to rodent glioma models with local administration of choline kinase inhibitor and acquisition of magnetic resonance images and spectra at 7 Tesla. The variations in the concentration of key metabolites measured by the device during the administration of the molecules demonstrate the relevance of the approach and the potential of the device.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the efficacy of anti - cancer drugs in brain tumors, especially in terms of real - time monitoring and local delivery. Specifically, the research aims to develop an implantable theranostic device to achieve real - time nuclear magnetic resonance (NMR) evaluation of the effect of drugs on brain tumors in vitro. This device combines the diagnostic functions of magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) with the therapeutic function of convection - enhanced delivery (CED) technology. ### Main problems and background 1. **Requirements for drug efficacy evaluation**: - Ideal drug efficacy evaluation should be fast, real - time, easy to perform, and reliable. - Adverse effects on patients should be minimized during the evaluation process. 2. **Limitations of systemic administration**: - Systemic administration (such as intravenous injection, oral administration) may lead to systemic distribution and produce side effects, especially being toxic to organs such as the heart, kidneys, and central nervous system in fragile patients. - For brain tumors, the blood - brain barrier (BBB) will limit the entry of some drugs into the extracellular fluid of the central nervous system, thereby reducing the efficacy. 3. **Advantages and challenges of local administration**: - Local administration can avoid the inconveniences brought by the drug passing through the blood system, such as dilution, binding to blood proteins, and first - pass effect. - Local administration allows the use of lower doses, reducing systemic toxicity. - However, local administration has some difficulties, such as the flow rate and dose during the injection process, the accessibility of the tumor site, and the dispersion of the drug in heterogeneous tumors and pharmacokinetic changes. 4. **Application of convection - enhanced delivery (CED) technology**: - CED continuously delivers drugs through an infusion catheter and applies a hydrostatic pressure gradient to promote the convective distribution of drugs within solid tumors. - A device capable of local analysis or imaging is required to evaluate the treatment effect and improve the chances of treatment success. ### Solution To solve the above problems, researchers have designed a miniaturized implantable theranostic device, which combines the following features: - **Integration of NMR detection coil and CED catheter**: Integrating the NMR micro - coil and CED catheter into a single implantable device realizes the combination of drug delivery and NMR diagnostic capabilities. - **High - resolution MRI and MRS**: Using MRI and MRS technologies to provide high - sensitivity metabolite concentration measurements in a small volume range and evaluate the effect of drugs on tumor cells and their microenvironment. - **Verification in animal models**: Experiments were carried out in a rat glioma model. By locally delivering a choline kinase inhibitor and obtaining MRI images and proton spectra under a 7 - Tesla magnetic field, the effectiveness of the device was verified. ### Conclusion This study shows the potential of this implantable theranostic device in evaluating the efficacy of anti - cancer drugs, especially in terms of real - time monitoring and local delivery. Future research can further expand its application range, not only limited to brain tumors, but also applicable to other types of cancers and other disease areas.

Implantable theranostic device for in vivo real-time NMR evaluation of drug impact in brain tumors

Biomimetic Multifunctional Persistent Luminescence Nanoprobes for Long-Term Near-Infrared Imaging and Therapy of Cerebral and Cerebellar Gliomas

Magnetic Nanoparticles for Tumor Imaging and Therapy: A So-Called Theranostic System

NIMG-01. MRI VIRTUAL BIOPSY AND TREATMENT OF PRIMARY OR BRAIN METASTATIC TUMORS WITH TARGETED NANOBIOCONJUGATES

Molecular Magnetic Resonance Imaging of Tumor Response to Therapy

An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors

Molecular Magnetic Resonance Imaging of Tumors with a PTPµ Targeted Contrast Agent.

In vivo imaging in a murine model of glioblastoma

Three in One: In Vitro and In Vivo Evaluation of Anticancer Activity of a Theranostic Agent that Combines Magnetic Resonance Imaging, Optical Bioimaging, and Photodynamic Therapy Capabilities

In vivo nanoparticle-based T cell imaging can predict therapy response towards adoptive T cell therapy in experimental glioma

A Hand-Held Magnetic Acoustic Device With Integrated Real-Time Monitoring for Targeted Drug Delivery

Small Animal In Situ Drug Delivery Effects via Transdermal Microneedles Array versus Intravenous Injection: A Pilot Observation Based on Photoacoustic Tomography

A Untethered Magnetic Micro-Robot for Local Therapeutic Delivery for Neurosurgical Oncology

Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles.

In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma

Minimally-invasive implantable device enhances brain cancer suppression

Two-order Targeted Brain Tumor Imaging by Using an Optical/paramagnetic Nanoprobe Across the Blood Brain Barrier.

Preclinical Application of CEST MRI to Detect Early and Regional Tumor Response to Local Brain Tumor Treatment

Magnetic Targeting Combined with Active Targeting of Dual-Ligand Iron Oxide Nanoprobes to Promote the Penetration Depth in Tumors for Effective Magnetic Resonance Imaging and Hyperthermia.

Multimodal In Vivo Tracking of Chimeric Antigen Receptor T Cells in Preclinical Glioblastoma Models

Efficacy of molecular and nano-therapies on brain tumor models in microfluidic devices